Inpatient and Outpatient Orderable

Hepatitis C Virus (HCV) NS5B Drug Resistance Assay (LabCorp)

Synonyms

HEPATITIS C NS5B DRUG RESISTANCE
LAB11835

Cerner Name

Clinical Info

Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5B inhibitors. Assay should be used for patients with documented HCV genotype 1.

Specimen Sources

Blood, Venous

Specimen Types

Blood

Specimen Volume

2 mL EDTA plasma (1 mL min)

Container

Lavender Top Tube

Collection Instructions

Container/Tube: Two Lavender-top (EDTA) tubes or two PPT™ tubes
Specimen: 2 mL EDTA plasma (1 mL min)
Transport Temperature: Frozen EDTA plasma (PPT™ tubes can be spun and frozen)
Collection : Centrifuge specimen within six hours of collection, remove serum/plasma, and transfer specimen to polypropylene screw-capped tubes, and freeze. Specimens drawn into PPT™ tubes need to be centrifuged within six hours and frozen.

Special Instructions Please indicate the patient's HCV genotype (1a or 1b) on the test request form

Transport Instructions

Frozen EDTA plasma (PPT™ tubes can be spun and frozen)

Specimen Stability

Methodology

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing

Days Performed

Performing Laboratory

LabCorp-Monogram Bioscience

CPT

87900
87902

TAT: 11- 15 Days

PDM

5908815

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
HCV NS5B DRUG RESISTANCE	HCVNS5B	HCV NS5B DRUG RESISTANCE	HCV NS5B Drug Resistance Assay
HCV NS5B RESIST INTERP	HCVNS5B	HCV NS5B RESIST INTERP	HCV NS5B Resist Assay Interp

Result Interpretation

See Report

This procedure may not be successful when the HCV viral load is <1000 IU/mL. This assay requires an HCV genotype of either 1a or 1b.

Forms

LAB11835

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });